The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

【葛兰素史克的液体脑膜炎疫苗获欧盟批准】葛兰素史克(GSK)的液体脑膜炎疫苗Menveo已获得欧盟委员会的批准，可在欧盟销售。这家英国制药公司周三表示，这种全液体疫苗有助于简化针对侵袭性脑膜炎球菌病(IMD)的疫苗接种流程，因为它为医疗健康提供者提供了一种无需在使用前进行复溶的选择。

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new ... Subscribe now to see this Premium News article from Alliance News ...